2Asci-Buturovi B,Kacila M,Kuli M.Effects of aggressive approach to the multiple risk factors for diabetic nephro-pathy on proteinuria reduction in diabetes type 2 patients[J].Bosn J Basic Med Sci,2009,9(1):44-48.
3陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:717-718.
4ADA.Standards of medical care in diabetes-2009[J].Diabetes Care,2009,32(l):13-61.
5The ADVANCE Collaborative Group.Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes[J].N Engl J Med,2008,358(24):2560-2572.
6Keech A,Simes RJ,Barter P,et al.Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):randomised controlled trial[J].Lancet,2005,366(9500):1849-1861.
7Parving HH,Persson F,Lewis JB,et al.Aliskiren combined with losartan in type 2 diabetes and nephropathy[J].N Engl J Med,2008,358(23):2433-2446.
8Gavrila D,Li WG,McCormick ML,et al.Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice[J].Arterioseler Thromb Vase Biol,2005,25(8):1671-1677.
2Alberti K G, Zimmet P Z . Definition , diagnosis and classification of diabetes mellitus and its eomplieation. Part 1 : diagnosis and elassifieation of diabetes mellitus provisional report of a WHO eonsultation[ J]. Diabet Med, 1998,15 (7) :539-553.
3Mogensen C E ,Schmitz A ,Christensen C K. Comparative renal pathophysiology relevant to IDDM and NIDDM patients [ J ]. Diabetes Metab Key, 1988,4 ( 5 ) :453-483.
4Kohan D E. Endothelins in the normal and diseased kidney [ J ]. Am J Kidney Dis, 1997,29 ( 1 ) : 2-26.
5Barzilay J l,Avraham L,Heckbert S R,et al. The relation of markers of inflammation to the development of glucose disorders in the elderly : the Cardiovascular Health Study [ J ]. Diabetes,2005,50(10) :2 384-2 389.
6Romano M, Pomilio M, Vigneri S, et al. Endothelial Perturbation in children and adolescents with type 1 diabetes:association with markers of the inflammatory reaction [ J]. Diabetes Care,2004,24 ( 9 ) : 1 674-1 678.
9Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy [ J ]. Diabetes, 1983,32 (Suppl) 2 : 64-78.
10Ascic-Buturovie B, Kacila M, Kulie M. Effects of aggressive approach to the multiple risk factors for diabetic nephro-pathy on proteinuria reduction in diabetes type 2 patients [J]. Bosh J Basic Med Sci,2009,9( 1 ) :44-48.
